Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Conference item
Title: What are the optimal systemic treatments for men with metastatic, hormone-sensitive prostate cancer? A STOPCaP systematic review and network meta-analysis
Author: Vale, C.
Fisher, D.
Carpenter, J.
White, I.
Burdett, S.
Clarke, N.
Fizazi, K.
Gravis, G.
James, N.
Mason, M.
Parmar, M.
Rydzewska, L.
Sweeney, C.
Spears, M.
Sydes, M.
Tierney, J.
Citation: Abstracts of the 42nd European Society for Medical Oncology Congress (ESMO 2017), as published in Annals of Oncology, 2017 / vol.28, iss.Suppl. 5, pp.620
Publisher: Oxford University Press
Issue Date: 2017
ISSN: 0923-7534
Conference Name: 42nd European Society for Medical Oncology Congress (ESMO 2017) (08 Sep 2017 - 12 Sep 2017 : Madrid, SPAIN)
Statement of
C.L. Vale, D.J. Fisher, J. Carpenter, I.R. White, S. Burdett, N.W. Clarke, K. Fizazi, G. Gravis, N.D. James, M.D. Mason, M.K. Parmar, L.H. Rydzewska, C.J. Sweeney, M.R. Spears, M.R. Sydes, J.F. Tierney
Keywords: Hormone
Description: Issue Section: Genitourinary tumours, prostate - Abstract #LBA33
Rights: © European Society for Medical Oncology 2017. Published by Oxford University Press. All rights reserved.
RMID: 0030090497
DOI: 10.1093/annonc/mdx440.026
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.